EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, LZAGF: Lonza Group Ag

17 Mar 2026
LAST:

622.5

CHANGE:
 13.04		OPEN:
631.6		HIGH:
631.6		ASK:
0.0		VOLUME:
1.5K
CHG(%):
2.14		PREV:
609.4		LOW:
598.0		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Mar 26631.6631.6598.0622.51.5K
16 Mar 26621.4628.3594.8609.4400
13 Mar 26621.0628.9598.8613.1400
12 Mar 26619.0641.2610.7621.1300
11 Mar 26652.1655.1606.6631.3200
10 Mar 26636.7668.5633.6662.9300
09 Mar 26639.8656.9613.3652.0100
06 Mar 26628.5670.0628.5661.5200
05 Mar 26651.0682.6651.0660.4100
04 Mar 26661.6693.6658.1679.5300

PROFILE

Name:Lonza Group Ag
About:Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Sector:Healthcare
Address:Muenchensteinerstrasse 38, Basel, Switzerland, 4002
Website:https://www.lonza.com
CIK:0001446711
FIGI:BBG000P5J2P8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:53.64 
Forward P/E:28.09 
Price to Sales:6.92 
Price to Book:4.45 
DivYield:0.01 
Div/Share:4.00 
Revenue:7.093B 
EBITDA:1.945B 
Shares:70.15M 
Market Cap:43.662B 

TECHNICAL INDICATORS

MA5:619.470.5%
MA10:641.363.0%
MA20:662.676.5%
MA50:682.589.7%
MA100:681.279.5%
MA200:689.4710.8%
STO9:17.81 
STO14:11.89 
RSI14:39.76 
WPR14:-85.35 
MTM14:-66.76
ROC14:-0.10 
ATR:39.84 
Week High:668.527.4%
Week Low:594.804.6%
Month High:719.0515.5%
Month Low:594.8010.8%
Year High:755.9621.4%
Year Low:560.5111.1%
Volatility:28.09